Filtered By:
Vaccination: Cervical Cancer Vaccine
Countries: USA Health
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 431 results found since Jan 2013.
Cervical Cancer Screening and Prevention among Survivors of Intimate Partner Violence
Health Soc Work. 2022 Apr 13;47(2):102-112. doi: 10.1093/hsw/hlac009.ABSTRACTWomen who experience intimate partner violence are an underserved population at risk for cervical cancer, precipitated by their heightened risk for human papilloma virus (HPV) and underutilization of gynecological care. This pilot study describes the self-reported behaviors, levels of knowledge, and perceived self-efficacy with cervical cancer screening (i.e., Pap testing) and prevention (i.e., HPV vaccination) among survivors (N = 30) recruited from two domestic violence shelter organizations in the midwestern United States. Survey results indica...
Source: Health and Social Work - March 21, 2022 Category: International Medicine & Public Health Authors: Meredith E Bagwell-Gray Megha Ramaswamy Source Type: research
Caregivers of Adolescents' Motivators and Barriers to Vaccinating Children Against Human Papillomavirus
J Prev (2022). 2022 Feb 20. doi: 10.1007/s10935-022-00674-3. Online ahead of print.ABSTRACTIn the United States (US), acceptance of adolescent vaccines, as measured by vaccine uptake in adolescents, is high amongst caregivers. However, this does not routinely extend to Human Papillomavirus (HPV) vaccination. In the US state of Georgia, HPV vaccine coverage rates remain suboptimal, especially when compared to other adolescent vaccines. Our study aims to identify and examine caregivers' motivators and barriers towards vaccinating their adolescents against HPV. We conducted nine focus groups with caregivers (n = 75) throughou...
Source: Cancer Control - March 14, 2022 Category: Cancer & Oncology Authors: Wintana Bairu Adrian R King Robert A Bednarczyk Source Type: research
Barriers and Factors Associated with HPV Vaccination Among American Indians and Alaska Natives: A Systematic Review
AbstractAmerican Indian and Alaska Native (AI/AN) persons bear a disproportionate burden of human papillomavirus (HPV)-associated cancers and face unique challenges to HPV vaccination. We undertook a systematic review to synthesize the available evidence on HPV vaccination barriers and factors among AI/AN persons in the United States. We searched fourteen bibliographic databases, four citation indexes, and six gray literature sources from July 2006 to January 2021. We did not restrict our search by study design, setting, or publication type. Two reviewers independently screened the titles and abstracts (stage 1) and full-t...
Source: Journal of Community Health - February 24, 2022 Category: International Medicine & Public Health Source Type: research
When and How Would You Screen This Patient for Cervical Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Ann Intern Med. 2022 Feb 8. doi: 10.7326/M21-4372. Online ahead of print.ABSTRACTSuccessful screening programs based on cervical cytology have dramatically reduced the incidence of cervical cancer in the United States. Human papillomavirus immunization is poised to reduce it further as an increasing percentage of vaccinated women reach adulthood. A recent guideline from the American Cancer Society advises that cervical cancer screening begin at age 25 and that high-risk human papillomavirus testing is the preferred screening test. The U.S. Preventive Services Task Force recommends screening begin at age 21 and that cytolog...
Source: Annals of Internal Medicine - February 7, 2022 Category: Internal Medicine Authors: Eileen E Reynolds Amy Weinstein Huma Farid Howard Libman Source Type: research
A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016
CONCLUSIONS: The high vaccine uptake and multitude of vaccine combinations administered concurrently in the adolescent population of the Vaccine Safety Datalink provide historical patterns with which to compare future adolescent vaccination campaigns.PMID:35125221 | DOI:10.1016/j.vaccine.2022.01.051
Source: Vaccine - February 7, 2022 Category: Allergy & Immunology Authors: Stephanie A Irving Holly C Groom Padma Dandamudi Matthew F Daley James G Donahue Julianne Gee Rulin Hechter Lisa A Jackson Nicola P Klein Elizabeth Liles Tanya R Myers Shannon Stokley Source Type: research
When and How Would You Screen This Patient for Cervical Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Ann Intern Med. 2022 Feb 8. doi: 10.7326/M21-4372. Online ahead of print.ABSTRACTSuccessful screening programs based on cervical cytology have dramatically reduced the incidence of cervical cancer in the United States. Human papillomavirus immunization is poised to reduce it further as an increasing percentage of vaccinated women reach adulthood. A recent guideline from the American Cancer Society advises that cervical cancer screening begin at age 25 and that high-risk human papillomavirus testing is the preferred screening test. The U.S. Preventive Services Task Force recommends screening begin at age 21 and that cytolog...
Source: Annals of Internal Medicine - February 7, 2022 Category: Internal Medicine Authors: Eileen E Reynolds Amy Weinstein Huma Farid Howard Libman Source Type: research
A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016
CONCLUSIONS: The high vaccine uptake and multitude of vaccine combinations administered concurrently in the adolescent population of the Vaccine Safety Datalink provide historical patterns with which to compare future adolescent vaccination campaigns.PMID:35125221 | DOI:10.1016/j.vaccine.2022.01.051
Source: Vaccine - February 7, 2022 Category: Allergy & Immunology Authors: Stephanie A Irving Holly C Groom Padma Dandamudi Matthew F Daley James G Donahue Julianne Gee Rulin Hechter Lisa A Jackson Nicola P Klein Elizabeth Liles Tanya R Myers Shannon Stokley Source Type: research
Missed opportunities for human papillomavirus vaccine series initiation in a large, rural U.S. state
Hum Vaccin Immunother. 2022 Feb 4:1-5. doi: 10.1080/21645515.2021.2016304. Online ahead of print.ABSTRACTHuman papillomavirus (HPV) vaccination rates are lower in rural versus urban areas of the United States. Our objective was to identify the types of vaccination clinic settings where missed opportunities for HPV vaccine series initiation most frequently occurred in Montana, a large, primary rural U.S. state. We analyzed a limited dataset from Montana's immunization information system for adolescents who turned 11 years old in 2014-2017. Vaccination visits where the HPV vaccine was due but not administered were missed opp...
Source: Cancer Control - February 4, 2022 Category: Cancer & Oncology Authors: Sophia R Newcomer Rain E Freeman Alexandria N Albers Sara Murgel Juthika Thaker Annie Rechlin Bekki K Wehner Source Type: research
"Everyone in our community should be informed about the HPV vaccine": Latinx mothers' suggested strategies to promote the human papillomavirus vaccine
CONCLUSION: Findings are relevant to the development of tailored interventions to meet the needs of Latinx populations, and ultimately increase Latinx children's HPV vaccination rates.PMID:35081770 | DOI:10.1177/08901171211073960
Source: American Journal of Health Promotion : AJHP - January 27, 2022 Category: International Medicine & Public Health Authors: Ana Cristina Lindsay Denisse Delgado Madelyne J Valdez Emily Restrepo Philip Granberry Source Type: research
